<?xml version="1.0" encoding="UTF-8"?>
<p>The administration of streptozotocin-/nicotinamide-induced diabetes is responsible of an increase rate of proinflammatory cytokines such as TNF-
 <italic>α</italic> (
 <xref ref-type="fig" rid="fig4">Figure 4(a)</xref>), IL-1
 <italic>β</italic> (
 <xref ref-type="fig" rid="fig4">Figure 4(b)</xref>), and IL-6 (
 <xref ref-type="fig" rid="fig4">Figure 4(c)</xref>) by 76.81%, 22.27%, and 32.04, respectively, while the increase rate of the anti-inflammatory factor IL-10 was 58.41% (
 <xref ref-type="fig" rid="fig4">Figure 4(d)</xref>) as compared to normal control. The treatment with hydroethanolic extract of 
 <italic>B. atroviridis</italic> induced a significant decrease (
 <italic>P</italic> &lt; 0.001) of TNF-
 <italic>α</italic> by 43.78%, 62.92%, and 58.38%, respectively, at the doses of 50, 100, and 200 mg/kg. The extract also showed a significant decrease of IL-1
 <italic>β</italic> by 17.62% (50 mg/kg), 33.68% (100 mg/kg), and 29.53% (200 mg/kg) after 15 days of treatment. The IL-10 concentration decreased by 65.08% (
 <italic>P</italic> &lt; 0.001), 67.30% (
 <italic>P</italic> &lt; 0.001), and 44.44% (
 <italic>P</italic> &lt; 0.05) at the respective dose of 50, 100, and 200 mg/kg. However, the plant extract failed to reduce (
 <italic>P</italic> &gt; 0.05) IL-6 concentration whatever the dose is.
</p>
